STOCK TITAN

Vanguard files 13G/A showing 0 shares in SI-BONE (SIBN)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SI-BONE Inc amendment: The Vanguard Group filed Amendment No. 1 to a Schedule 13G/A reporting zero shares beneficially owned of SI-BONE Inc common stock, representing 0% of the class. The filing explains an internal realignment that caused certain Vanguard subsidiaries to report ownership separately in reliance on SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Amendment reflects reporting reallocation, not an economic stake change.

The filing states 0 shares beneficially owned and 0% of the class; it attributes the change to an internal realignment and disaggregation under SEC Release No. 34-39538.

Cash‑flow treatment and market activity are not disclosed; subsequent filings from the named Vanguard entities may show holdings if applicable.






825704109

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What did The Vanguard Group report for SI-BONE (SIBN)?

The Vanguard Group reported 0 shares beneficially owned, equal to 0% of SI-BONE Inc common stock. The filing attributes the reporting change to an internal realignment and disaggregation under SEC Release No. 34-39538.

Does this filing indicate Vanguard sold or bought SI-BONE shares?

No. The amendment explains an internal organizational realignment that changed reporting lines; it does not state any purchase or sale. The filing reports the resulting beneficial ownership as 0 shares and 0% of the class.

Why did Vanguard report zero ownership in this 13G/A amendment?

The filing states that Vanguard reorganized and certain subsidiaries now report separately in reliance on SEC Release No. 34-39538. As a result, The Vanguard Group, Inc. no longer reports beneficial ownership for securities held by those subsidiaries.

Who signed the Schedule 13G/A amendment for SIBN?

The amendment was signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026. The signature attests to the reported ownership and the explanatory disclosure about the internal realignment.

Does this amendment change SI-BONE's outstanding share count or issuer information?

No. The filing only addresses beneficial ownership reporting by The Vanguard Group and cites its address and issuer headquarters. It does not state any change to SI-BONE's outstanding shares or corporate capitalization.
Si-Bone

NASDAQ:SIBN

View SIBN Stock Overview

SIBN Rankings

SIBN Latest News

SIBN Latest SEC Filings

SIBN Stock Data

567.08M
42.58M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA